Stop TB Partnership

#htmlcaption_a #htmlcaption_b #htmlcaption_c #htmlcaption_d #htmlcaption_e

Global TB Conference 2015, Bangkok

Organized by USAID’s SIAPS & GDF

GDF: Price of MDR-TB drug Cycloserine cut by half in 2015

Significant savings on account of price reduction.

Need to increase TB expertise in CCMs

New analysis shows insufficient TB expertise in CCMs.

TB Europe Coalition:
Fight TB 2015 campaign

Campaign for European leaders to step up their response to TB.

"Reach, Treat, Cure Everyone"

Stop TB Partnership announces theme for World TB Day 2015


26 February - Romania's Ministry of Health approves the country's National...Romania's Ministry of Health approves the country's National Strategy for TB Control 2015-2020
26 February 2015 - Romania - The Romanian government this week approved the National Strategy for TB Control for the period 2015-2020. The Strategy aims to reduce TB incidence and mortality by providing prevention, screening, diagnosis, treatment and an increased adherence to treatment as recommended by WHO. Despite progress in the last 12 years, Romania still has one of the highest rates of TB in the European Union. It is four times above the EU average, and it has one of the lowest rates of treatment success with rising rates of TB infection.

25 February - The Centre for Operational Research: Setting the StandardThe Centre for Operational Research: Setting the Standard
25 February, 2015 - In 2012, The Union’s Centre for Operational Research (COR) and Médecins Sans Frontières (MSF) entered into a global partnership with the World Health Organization to develop a new approach to training researchers, which involves close mentorship and requires all participants to conduct original operational research and carry it through to publication in a peer-reviewed journal. The UK Department of International Development commissioned a recently completed in-depth independent evaluation that found this programme is highly effective and sets the standard for operational research capacity building.

25 February - MSF and partners launch a new call to action to help accelerate...MSF and partners launch a new call to action to help accelerate access to new DR-TB drugs
25 February 2015 - Médecins Sans Frontières (MSF), Treatment Action Campaign (TAC), Treatment Action Group (TAG) and others are calling on global health actors to step up and ensure new and repurposed DR-TB drugs reach people who are otherwise without treatment options.

24 February - Stop TB Partnership's Global Drug Facility (GDF) achieves historic...Stop TB Partnership's Global Drug Facility (GDF) achieves historic price reduction for MDR-TB drug Cycloserine
24 February - Geneva - The Global Drug Facility (GDF) of the Stop TB Partnership, has announced that the price of Cycloserine - a key medicine to treat multi-drug resistant TB (MDR-TB) - will be cut by half (55%) in 2015 compared to the previous year. This price reduction is expected to save up to USD 22 million annually, enabling treatment for more people living with MDR-TB.

24 February - Scaling up of MDR-TB case detection in LiraScaling up of MDR-TB case detection in Lira
24 February 2015 - Kampala, Uganda - Even though Uganda has achieved the millennium development goal in fighting TB, Multi Drug Resistant TB (MDR-TB) still remains a growing concern for the nation. This is especially so in the Northern part of Uganda. Lira district one of the districts in northern Uganda remains a hotspot for MDR-TB. This may be attributed to the peri-urban status of the district as it continues to attract a number of people for commercial as well as other strategic reasons.

24 February - Daniel Chin Receives Top Award from China for Contribution to TB...Daniel Chin Receives Top Award from China for Contribution to TB Control
24 February 2015 - The Gates Foundation is delighted to announce that Daniel Chin, Senior Program Officer, TB, has been awarded the prestigious "Chinese Medical Science and Technology Award." This annual award, established in 2001 by the National Health and Family Planning Commission (formerly the Ministry of Health) and the Ministry of Science and Technology, is a top national award presented to individuals and organizations that have made considerable contributions to innovation in medical science and technology in China. Recipients are selected by national expert committees brought together by the Chinese Medical Association.



We set goals to fight TB globally. We grant funds to reach and treat people living with TB. We strive to raise the profile and understanding of TB. We bring the voice of TB communities to the fore. We procure drugs and diagnostics.

We work together with our partners to create a world without TB.

We are the Stop TB Partnership.

Read Our Brochure